This inventor holds 1 USPTO granted patent. Top assignee: Basf Aktiengesellschaft. Active years: 1983.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 1983
Title: The Innovative Mind of Hans-Juegen Teschendorf
Introduction: Hans-Juegen Teschendorf, a notable inventor from Ludwigshafen, Germany, has made significant contributions to the field of pharmaceuticals. With an impressive patent under his name, his work focuses on innovative compounds that have the potential to improve mental health and alleviate various neurological conditions.
Latest Patents: Teschendorf's sole patent is titled "6(1-Piperazinyl), piperidino and (1(homopiperazinyl)11-cyanomethylene - 6-Substituted 11-alkylene-morphanthridines," which is more commonly referred to as "11-alkylene-dibenzo[b,e]-azepines." This patent encompasses the pure cis- and trans-isomers of these compounds, outlining processes for their preparation and highlighting their use as therapeutic agents. These compounds are particularly valuable as potential drugs, including neuroleptics, sedatives, hypnotics, analgesics, antidepressants, and agents for treating Parkinson's syndrome.
Career Highlights: Teschendorf is associated with BASF Aktiengesellschaft, a leading global chemical company that specializes in producing and developing a wide range of innovative products. His position at BASF reflects his commitment to advancing pharmaceutical research and development.
Collaborations: Throughout his career, Hans-Juegen Teschendorf has collaborated with other esteemed professionals in the field, such as Gerd Steiner and Albrecht Franke. These partnerships have undoubtedly enriched his innovative approach and led to groundbreaking developments in pharmaceutical technology.
Conclusion: Hans-Juegen Teschendorf stands out as a prominent figure in the realm of medicinal chemistry. His patented innovations represent a significant step forward in the design of therapeutic agents, potentially improving the quality of life for individuals suffering from various mental health disorders. His work continues to inspire future advancements in the field, reinforcing the importance of collaboration and creativity in scientific research.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile